144 related articles for article (PubMed ID: 27859978)
1. Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.
Konuma T; Takahashi S; Kiyuna T; Miharu Y; Suzuki M; Shibata H; Kato S; Takahashi S; Tojo A
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27859978
[TBL] [Abstract][Full Text] [Related]
2. Three cases of Candida fermentati fungemia following hematopoietic stem cell transplantation.
Morita K; Honda A; Koya J; Toyama K; Ikeda M; Misawa Y; Okugawa S; Nakamura F; Moriya K; Kurokawa M
J Infect Chemother; 2018 Jul; 24(7):576-578. PubMed ID: 29371065
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin.
Bizerra FC; Jimenez-Ortigosa C; Souza AC; Breda GL; Queiroz-Telles F; Perlin DS; Colombo AL
Antimicrob Agents Chemother; 2014; 58(4):2438-40. PubMed ID: 24468776
[TBL] [Abstract][Full Text] [Related]
4. Development of echinocandin-resistant Candida albicans candidemia following brief prophylactic exposure to micafungin therapy.
Ruggero MA; Topal JE
Transpl Infect Dis; 2014 Jun; 16(3):469-72. PubMed ID: 24810789
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
Kimura M; Araoka H; Yamamoto H; Asano-Mori Y; Nakamura S; Yamagoe S; Ohno H; Miyazaki Y; Abe M; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Uchida N; Izutsu K; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115352
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
[TBL] [Abstract][Full Text] [Related]
7. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough invasive candidiasis in patients on micafungin.
Pfeiffer CD; Garcia-Effron G; Zaas AK; Perfect JR; Perlin DS; Alexander BD
J Clin Microbiol; 2010 Jul; 48(7):2373-80. PubMed ID: 20421445
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC.
Saraya T; Tanabe K; Araki K; Yonetani S; Makino H; Watanabe T; Tsujimoto N; Takata S; Kurai D; Ishii H; Miyazaki Y; Takizawa H; Goto H
J Clin Microbiol; 2014 Jul; 52(7):2709-12. PubMed ID: 24789192
[TBL] [Abstract][Full Text] [Related]
10. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.
Lallitto F; Prigitano A; Mangione F; Piralla A; Tamarozzi F; Marone P; Cavanna C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):311-314. PubMed ID: 30131237
[TBL] [Abstract][Full Text] [Related]
11. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
[TBL] [Abstract][Full Text] [Related]
12. [Case of candidemia with Candida glabrata with confirmation of the acquisition of micafungin sensitivity due to new mutation of FKS gene mutation].
Saraya T; Watanabe T; Tsujimoto N; Takata S; Araki K; Makino H; Yonetani S; Takizawa H; Goto H
Kansenshogaku Zasshi; 2014 May; 88(3 Suppl 9-10):1-5. PubMed ID: 25033496
[No Abstract] [Full Text] [Related]
13. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Cleary JD; Garcia-Effron G; Chapman SW; Perlin DS
Antimicrob Agents Chemother; 2008 Jun; 52(6):2263-5. PubMed ID: 18378714
[TBL] [Abstract][Full Text] [Related]
14. Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
Al-Sweih N; Ahmad S; Joseph L; Khan S; Vayalil S; Chandy R; Khan Z
J Clin Microbiol; 2015 Mar; 53(3):1038-41. PubMed ID: 25568433
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough Candida guilliermondii (Meyerozyma guilliermondii) fungemia after cord blood transplantation for extranodal NK-cell lymphoma with azole prophylaxis.
Nakazawa H; Nishina S; Senoo Y; Sakai H; Ito T; Kikuchi K; Ishida F
Transpl Infect Dis; 2018 Aug; 20(4):e12922. PubMed ID: 29797683
[TBL] [Abstract][Full Text] [Related]
16. Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin.
Slater JL; Howard SJ; Sharp A; Goodwin J; Gregson LM; Alastruey-Izquierdo A; Arendrup MC; Warn PA; Perlin DS; Hope WW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3075-83. PubMed ID: 21502627
[TBL] [Abstract][Full Text] [Related]
17. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
[TBL] [Abstract][Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
19. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
20. [Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation].
Okinaka K
Med Mycol J; 2016; 57(3):J117-23. PubMed ID: 27581780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
